STRATA Skin Sciences, Inc. (SSKN)
SSKN Stock Price Chart
Explore STRATA Skin Sciences, Inc. interactive price chart. Choose custom timeframes to analyze SSKN price movements and trends.
SSKN Company Profile
Discover essential business fundamentals and corporate details for STRATA Skin Sciences, Inc. (SSKN) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
3 Nov 2005
Employees
106.00
CEO
Dolev Rafaeli
Description
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. Its products include XTRAC and Pharos excimer lasers, VTRAC lamp systems, and TheraClear treatment systems that are used for the treatment of psoriasis, vitiligo, acne, and other skin conditions. The company distributes its products internationally through distributors, and domestically directly to physicians. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.
SSKN Financial Timeline
Browse a chronological timeline of STRATA Skin Sciences, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 12 May 2026
Upcoming earnings on 12 Nov 2025
EPS estimate is -$0.24, while revenue estimate is $7.72M.
Earnings released on 13 Aug 2025
EPS came in at -$0.60 falling short of the estimated -$0.24 by -150.00%, while revenue for the quarter reached $7.66M , missing expectations by -13.30%.
Earnings released on 14 May 2025
EPS came in at -$0.58 falling short of the estimated -$0.52 by -11.54%, while revenue for the quarter reached $6.81M , missing expectations by -6.44%.
Earnings released on 27 Mar 2025
EPS came in at -$1.13 falling short of the estimated -$0.30 by -276.67%, while revenue for the quarter reached $9.58M , beating expectations by +6.68%.
Earnings released on 13 Nov 2024
EPS came in at -$0.53 falling short of the estimated -$0.44 by -20.45%, while revenue for the quarter reached $8.80M , missing expectations by -2.58%.
Earnings released on 14 Aug 2024
EPS came in at -$0.03 surpassing the estimated -$0.70 by +95.71%, while revenue for the quarter reached $8.44M , beating expectations by +13.68%.
Stock split effective on 7 Jun 2024
Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 15 May 2024
EPS came in at -$1.00 falling short of the estimated -$0.07 by -1.33K%, while revenue for the quarter reached $6.75M , missing expectations by -2.26%.
Earnings released on 27 Mar 2024
EPS came in at -$0.40 falling short of the estimated -$0.07 by -449.98%, while revenue for the quarter reached $8.69M , missing expectations by -13.20%.
Earnings released on 14 Nov 2023
EPS came in at -$0.30 falling short of the estimated -$0.24 by -25.00%, while revenue for the quarter reached $8.85M , missing expectations by -11.57%.
Earnings released on 9 Aug 2023
EPS came in at -$0.90 falling short of the estimated -$0.05 by -1.70K%, while revenue for the quarter reached $8.25M , missing expectations by -14.42%.
Earnings released on 15 May 2023
EPS came in at -$0.80 falling short of the estimated -$0.07 by -1.04K%, while revenue for the quarter reached $7.57M , missing expectations by -22.63%.
Earnings released on 31 Mar 2023
EPS came in at -$0.00 surpassing the estimated -$0.05 by +90.78%, while revenue for the quarter reached $10.60M , beating expectations by +7.96%.
Earnings released on 9 Nov 2022
EPS came in at -$0.30 surpassing the estimated -$0.60 by +50.00%, while revenue for the quarter reached $9.41M , beating expectations by +16.57%.
Earnings released on 10 Aug 2022
EPS came in at -$0.50 falling short of the estimated -$0.40 by -25.00%, while revenue for the quarter reached $9.11M , beating expectations by +11.68%.
Earnings released on 11 May 2022
EPS came in at -$0.70 falling short of the estimated -$0.50 by -40.00%, while revenue for the quarter reached $7.04M , beating expectations by +1.35%.
Earnings released on 21 Mar 2022
EPS came in at -$0.20 surpassing the estimated -$0.30 by +33.33%, while revenue for the quarter reached $14.56M , beating expectations by +62.22%.
Earnings released on 10 Nov 2021
EPS came in at -$0.20 surpassing the estimated -$0.40 by +50.00%, while revenue for the quarter reached $7.71M , missing expectations by -25.93%.
Earnings released on 16 Aug 2021
EPS came in at -$0.30 surpassing the estimated -$0.60 by +50.00%, while revenue for the quarter reached $7.38M , missing expectations by -1.97%.
Earnings released on 12 May 2021
EPS came in at -$0.70 falling short of the estimated -$0.30 by -133.33%, while revenue for the quarter reached $5.83M , beating expectations by +7.74%.
Earnings released on 24 Mar 2021
EPS came in at -$0.10 surpassing the estimated -$0.20 by +50.00%, while revenue for the quarter reached $6.72M .
Earnings released on 10 Nov 2020
EPS came in at -$0.40 falling short of the estimated -$0.30 by -33.33%, while revenue for the quarter reached $5.61M , meeting expectations.
SSKN Stock Performance
Access detailed SSKN performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.